GLP-1 based drugs are transforming the treatment of obesity and opening up new avenues for addressing heart disease, addiction, and even Alzheimers
Although Novo Nordisk has replied to FDA communications about these citations, the FDA says its replies fail to determine whether your actions will effectively prevent similar violations in the future. Novo Nordisk has 15 business days to provide the FDA with written communication regarding actions taken to prevent future reporting infractions
If any contravention of the law is suspected, the DH will follow up and carry out enforcement action
Ginsenoside Rd (PubChem CID: 11679800) exhibits diverse pharmacological properties including cardiovascular protection, neuroprotection, anti-aging, anti-tumor, and more (Chen et al., 2022c)
We use the BPC-157 capsules from InfiniWell as they use the arginate salt which is the better form of BPC